The Brazilian biofuel pioneer, Be8, and the U.S.-based leader in the development of innovative biotech solutions, Cemvita, signed a Memorandum of Understanding (MOU) on Tuesday, January 21, at Brazil ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,285.92 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

Pre-Market: 9:28:52 a.m. EST ...

SAR-442970 is under clinical development by Sanofi and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase II drugs for Hidradenitis Suppurativa have a 44% phase ...